Products Categories
| CAS No.: | 106650-56-0 |
|---|---|
| Name: | Sibutramine |
| Article Data: | 18 |
| Molecular Structure: | |
|
|
|
| Formula: | C17H26ClN |
| Molecular Weight: | 279.853 |
| Synonyms: | UNII-WV5EC51866;Didemethylsibutramine hydrochloride;Medaria;Racemic sibutramine; |
| Density: | 1.031 g/cm3 |
| Melting Point: | 191-192 °C |
| Boiling Point: | 342.6 °C at 760 mmHg |
| Flash Point: | 161 °C |
| Solubility: | Water solubility: 2.9 mg/mL |
| Appearance: | Yellowish solid |
| Transport Information: | 25kgs |
| PSA: | 3.24000 |
| LogP: | 4.73800 |
- 144851-82-1METHYL2-AMINO-3-FLUOROBENZOATE
- 483366-12-7(2S,4R)-1-Boc-2-cyano-4-hydroxypyrrolidine
- 173606-50-3BOC-10-AMINODECANOIC ACID
- 361456-36-2METHYL (R)-(+)-ISOCYANATO-3-PHENYLPROPI&
- 5156-58-1N-(1-Benzyl-4-pipperidinyl)-N-phenylpropanamide HCl
- 81281-59-67-Benzylideneaminotheophylline
- 50288-62-5threo-Phenyl-2-piperidyl acetamide
- 82993-81-5D-threo-Ritalinic acid hydrochloride
- 47087-37-6Z-D-Glu-OMe
- 1219080-61-1IMIDAZOLE-2-BORONIC ACID
This product is a nationally controlled contraband, and the Lookchem platform doesn't provide relevant sales information.
Chemistry
Molecular Structure:
Molecular Formula: C17H26ClN
Molecular Weight: 279.848
IUPAC Name: 1-[1-(4-Chlorophenyl)cyclobutyl]-N,N,3-trimethylbutan-1-amine
Synonyms of Sibutramine (CAS NO.106650-56-0): Sibutramine [INN:BAN] ; Medaria ; Reductil ; Sibutramina ; Sibutramina [Spanish] ; Sibutraminum ; Sibutraminum [Latin] ; UNII-WV5EC51866 ; Cyclobutanemethanamine, 1-(4-chlorophenyl)-N,N-dimethyl-alpha-(2-methylpropyl)- ; DEA No. 1675
CAS NO: 106650-56-0
Classification Code: Anti-Obesity Agents ; Antidepressive agents ; Appetite depressants ; Central Nervous System Agents ; Psychotropic Drugs
Melting point: 191-192°C
Index of Refraction: 1.529
Molar Refractivity: 83.76 cm3
Molar Volume: 271.3 cm3
Surface Tension: 37.3 dyne/cm
Density: 1.031 g/cm3
Flash Point: 161 °C
Enthalpy of Vaporization: 58.64 kJ/mol
Boiling Point: 342.6 °C at 760 mmHg
Vapour Pressure: 7.45E-05 mmHg at 25°C
Uses
Sibutramine (CAS NO.106650-56-0) has been used as an appetite suppressant administered orally for the treatment of obesity.
Specification
Sibutramine (CAS NO.106650-56-0) is a centrally-acting serotonin-norepinephrine reuptake inhibitor structurally related to amphetamines, and is also under review by the FDA and the European Medicines Agency. It is classified as a Schedule IV controlled substance in the United States, despite having virtually no potential for misuse due to its lack of appreciable dopaminergic effects. As a neurotransmitter reuptake inhibitor, it reduces the reuptake of serotonin (by 53%), norepinephrine (by 54%), and dopamine (by 16%), thereby increasing the levels of these substances in synaptic clefts and helping enhance satiety. It has a number of clinically significant interactions, and a higher number of cardiovascular events has been observed in people taking it verses control (11.4% vs. 10.0%).